Yuqing Li Selected Research

Yuqing Li Research Topics

Disease

40	Neoplasms (Cancer) 05/2024 - 09/2004
23	Dystonia musculorum deformans type 1 01/2023 - 12/2005
22	Infections 01/2024 - 11/2010
18	Dystonia (Limb Dystonia) 01/2023 - 12/2005
12	Dental Caries (Decay, Dental) 02/2024 - 01/2016
10	Breast Neoplasms (Breast Cancer) 06/2023 - 01/2006
9	Obesity 05/2024 - 01/2023
8	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 12/2015
7	Inflammation (Inflammations) 11/2023 - 01/2020
6	Hypertension (High Blood Pressure) 03/2024 - 01/2023
6	Restless Legs Syndrome (Restless Legs) 08/2023 - 01/2018
6	Movement Disorders (Movement Disorder) 02/2015 - 12/2005
5	Anemia 08/2023 - 11/2019
5	Renal Cell Carcinoma (Grawitz Tumor) 12/2021 - 10/2019
5	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 05/2004
4	Bacterial Infections (Bacterial Infection) 01/2024 - 06/2022
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 01/2023
4	Cognitive Dysfunction 12/2022 - 01/2019
4	Myoclonic dystonia 02/2012 - 08/2005
3	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2023
3	Myocardial Infarction 11/2023 - 01/2022
3	Iron Deficiencies 01/2023 - 11/2019
3	Carcinogenesis 01/2022 - 01/2011
3	Huntington Disease (Huntington's Disease) 01/2022 - 05/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 05/2014
3	Psychomotor Agitation (Akathisia) 12/2020 - 09/2012
3	Dental Plaque 12/2018 - 12/2013
3	Tuberculosis (Tuberculoses) 06/2017 - 07/2009
3	Myoclonus (Nocturnal Myoclonus) 02/2012 - 07/2006
2	Sepsis (Septicemia) 03/2024 - 06/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 01/2022
2	Disease Resistance 01/2024 - 08/2021
2	COVID-19 01/2024 - 01/2020
2	Neoplasm Metastasis (Metastasis) 08/2023 - 01/2022
2	Diarrhea 06/2023 - 02/2020
2	Kidney Neoplasms (Kidney Cancer) 05/2023 - 01/2021
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023 - 12/2022
2	Pneumonia (Pneumonitis) 01/2023 - 01/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2022
2	Reperfusion Injury 01/2023 - 10/2021
2	Chronic Disease (Chronic Diseases) 01/2023 - 01/2021
2	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2022 - 11/2019

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2005
9	LipidsIBA 05/2024 - 01/2023
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2016
8	Methamphetamine (Desoxyn)FDA LinkGeneric 03/2024 - 01/2011
8	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2013
7	Dopamine (Intropin)FDA LinkGeneric 08/2023 - 12/2005
7	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 07/2009
7	Glutamic Acid (Glutamate)FDA Link 01/2023 - 04/2007
7	Dopamine Receptors (Dopamine Receptor)IBA 07/2022 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2016
6	Cholinergic Agents (Cholinergics)IBA 07/2022 - 01/2012
5	CholesterolIBA 01/2024 - 10/2021
5	Triglycerides (Triacylglycerol)IBA 01/2024 - 01/2023
5	IronIBA 08/2023 - 09/2012
5	Hormones (Hormone)IBA 01/2023 - 07/2010
5	Long Noncoding RNAIBA 11/2022 - 07/2018
5	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
5	Sarcoglycans (beta Sarcoglycan)IBA 02/2012 - 08/2005
5	Estrogens (Estrogen)FDA Link 01/2012 - 05/2009
5	Estrogen ReceptorsIBA 01/2012 - 07/2009
4	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2020
4	Opioid Analgesics (Opioids)IBA 08/2023 - 11/2019
4	Tyrosine Kinase InhibitorsIBA 05/2023 - 01/2020
4	CytokinesIBA 03/2022 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2016
4	Messenger RNA (mRNA)IBA 01/2022 - 02/2015
4	Trihexyphenidyl (Artane)FDA LinkGeneric 12/2021 - 01/2012
3	Endocrine DisruptorsIBA 11/2023 - 01/2021
3	Arginine (L-Arginine)FDA Link 01/2023 - 01/2021
3	Therapeutic UsesIBA 01/2023 - 01/2022
3	6-methyladenineIBA 01/2023 - 11/2020
3	Sunitinib (Sutent)FDA Link 12/2022 - 09/2021
3	Opioid Receptors (Opioid Receptor)IBA 10/2022 - 11/2019
3	CalciumIBA 07/2022 - 12/2013
3	InflammasomesIBA 05/2022 - 01/2022
3	Polysaccharides (Glycans)IBA 08/2021 - 12/2018
3	AcidsIBA 01/2021 - 12/2005
3	Cholinergic Antagonists (Anticholinergics)IBA 06/2013 - 01/2012
2	Immune Checkpoint InhibitorsIBA 05/2024 - 11/2023
2	SaponinsIBA 04/2024 - 01/2021
2	VaccinesIBA 01/2024 - 06/2017
2	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 01/2021
2	Indicators and Reagents (Reagents)IBA 09/2023 - 03/2023
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 09/2017
2	GlucansIBA 01/2023 - 01/2016
2	GoldIBA 01/2023 - 01/2023
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2023 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 05/2020
2	AntibodiesIBA 01/2023 - 01/2019
2	AerosolsIBA 01/2023 - 01/2020
2	N-methyladenosineIBA 12/2022 - 11/2020
2	Peptides (Polypeptides)IBA 11/2022 - 01/2021
2	CXC ChemokinesIBA 08/2022 - 09/2021

Therapy/Procedure

24	Therapeutics 05/2024 - 05/2010
4	Immunotherapy 05/2024 - 01/2021
3	Drug Therapy (Chemotherapy) 01/2024 - 01/2022
2	Renal Dialysis (Hemodialysis) 03/2024 - 01/2020